Skip to main content
Clinical Trials/NCT01106547
NCT01106547
Completed
Phase 4

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study

Holbaek Sygehus1 site in 1 country55 target enrollmentAugust 2009

Overview

Phase
Phase 4
Intervention
Methylprednisolone 125mg
Conditions
Hysterectomy
Sponsor
Holbaek Sygehus
Enrollment
55
Locations
1
Primary Endpoint
Pain 6 hours postoperatively
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered:

  1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery.
  2. The postoperative use of additional analgesics.
  3. Inflammatory parameters before and after surgery.
  4. Time until mobilization.
  5. Time until discharge.
Registry
clinicaltrials.gov
Start Date
August 2009
End Date
October 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Holbaek Sygehus
Responsible Party
Principal Investigator
Principal Investigator

Anna Aabakke

Anna Aabakke, M.D.

Holbaek Sygehus

Eligibility Criteria

Inclusion Criteria

  • Patients having an abdominal hysterectomy on a benign indication.
  • Patients who speak and understand Danish.
  • Patients who can give informed consent.

Exclusion Criteria

  • Diabetics
  • Regular use of glucocorticoids, opioids or tranquilizers
  • Regular treatment with immunosuppressives
  • Alcohol or drug abuse
  • Morphine intolerance
  • Age under 18
  • Chronic pain disease eg fibromyalgia, rheumatoid arthritis
  • Malign indication for hysterectomy
  • BMI over 35
  • Decreased kidney function

Arms & Interventions

Methylprednisolone

Intervention: Methylprednisolone 125mg

placebo/sodium chloride

Intervention: Sodium Chloride 2 ml

Outcomes

Primary Outcomes

Pain 6 hours postoperatively

Time Frame: 6 hours postoperatively

Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively

Pain 3 hours postoperatively

Time Frame: 3 hours postoperatively

Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively

Pain 24 hours postoperatively

Time Frame: 24 hours postoperatively

Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively

Pain

Time Frame: 2-7 days postoperatively

Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day

Secondary Outcomes

  • Use of additional analgesics(0-2 days)
  • Postoperative nausea(until 2 days postoperatively)
  • Use of antiemetics(0-2 days postoperatively)
  • Time until mobilization(0-2 days)
  • Time until discharge after surgery(0-10 days)
  • Inflammatory parameters(0-24 h preoperatively)
  • Adverse effects(0-2 days)
  • Inflammatory parameter(1-2 days postoperative)

Study Sites (1)

Loading locations...

Similar Trials